Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-053820
Filing Date
2023-10-17
Accepted
2023-10-17 17:52:53
Documents
1
Period of Report
2023-10-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3853
  Complete submission text file 0000950170-23-053820.txt   5179
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CRISPR THERAPEUTICS, INC. 105 W FIRST STREET BOSTON MA 02127
Business Address
Prasad Raju (Reporting) CIK: 0001968317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 231330507